Home › Funds › Verdad Advisers, LP › MNPR
Verdad Advisers, LP position in MNPR
MONOPAR THERAPEUTICS INC · Health Care
Verdad Advisers, LP reported holding 8,409 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$670K, representing 0.72% of its reported portfolio and ranking #45 among its reported holdings. Verdad Advisers, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Verdad Advisers, LP's MNPR position evolved
Verdad Advisers, LP first disclosed a stake in MNPR in Q3 2026 at 8,409 shares (US$670K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 8.41K | $669.95K | New |
About MNPR and 13F data
MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$24.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MNPR
- RA CAPITAL MANAGEMENT, L.P. 667.21K sh · $61.78M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 323.75K sh · $29.98M · Q2 2026
- Saturn V Capital Management LP 312.35K sh · $24.88M · Q3 2026
- Siren, L.L.C. 270.12K sh · $21.52M · Q3 2026
- TCG Crossover Management, LLC 202.24K sh · $16.11M · Q3 2026
- ADAR1 Capital Management, LLC 179.03K sh · $14.26M · Q3 2026
- Vivo Capital, LLC 90.50K sh · $7.21M · Q3 2026
- Ikarian Capital, LLC 47.86K sh · $4.43M · Q2 2026
- Ishara Investments LP 12.00K sh · $956.04K · Q3 2026
More on Verdad Advisers, LP
FAQ
How long has Verdad Advisers, LP held MNPR?
Verdad Advisers, LP has disclosed MNPR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Verdad Advisers, LP's current position in MNPR?
As of Q3 2026, Verdad Advisers, LP holds 8.41K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $669.95K, representing 0.72% of its reported portfolio and ranking #45.
Has Verdad Advisers, LP been buying or selling MNPR?
In the latest 13F filing (Q3 2026), Verdad Advisers, LP newly opened its position in MNPR.
Which other funds hold MNPR?
Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.